kras mutation and glutathion Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex The Role of KRAS Mutations
The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy Uncovering new therapeutic targets for a common KRAS mutation behind cancer
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




